| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJM199006073222306 |
| P698 | PubMed publication ID | 2342524 |
| P2093 | author name string | Chapman RH | |
| Surgenor DM | |||
| Wallace EL | |||
| Hao SH | |||
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1646-1651 | |
| P577 | publication date | 1990-06-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Collection and transfusion of blood in the United States, 1982-1988. | |
| P478 | volume | 322 |
| Q40457361 | A model for predicting transfusion requirements in head and neck surgery |
| Q40458935 | A multicenter randomized, double-blind, placebo-controlled late-phase II/III study of recombinant human interleukin 11 in acute myelogenous leukemia. |
| Q73277641 | A retrospective analysis of microbial contaminants in outdated random-donor platelets from multiple sites |
| Q42143232 | A survey of resident physicians' knowledge concerning transfusion medicine in Shiraz, Iran |
| Q45883125 | AIDS: safety, regulation and the law in procedures using blood and blood products |
| Q42480130 | Anemia in cervical cancer patients: implications for iron supplementation therapy |
| Q73126416 | Annexin V and platelet antigen expression is not altered during storage of platelet concentrates obtained with the AMICUS cell separator |
| Q24550050 | Are worry-free transfusions just a whiff of ozone away? |
| Q58116812 | Blood Donation and Transfusion: A Primer for Health Educators |
| Q37139521 | Blood component treatment: a retrospective audit in five major London hospitals |
| Q70857553 | Blood conservation strategies to minimize allogeneic blood use in urologic surgery |
| Q40568300 | Blood transfusion and blood conservation: cost and utilization issues |
| Q40742336 | Blood transfusion reactions. Which are life-threatening and which are not? |
| Q42635162 | Blood transfusions in radical prostatectomy: a contemporary population-based analysis. |
| Q24235950 | Cell salvage for minimising perioperative allogeneic blood transfusion |
| Q24236501 | Cell salvage for minimising perioperative allogeneic blood transfusion |
| Q24243907 | Cell salvage for minimising perioperative allogeneic blood transfusion |
| Q24247755 | Cell salvage for minimising perioperative allogeneic blood transfusion |
| Q40590477 | Clinical application of recombinant erythropoietin in the perioperative period. |
| Q33332593 | Clinical issues and treatment advances in thrombocytopenia: introduction |
| Q37589285 | Consensus and controversies in platelet transfusion |
| Q38738078 | Continued decline in blood collection and transfusion in the United States-2015 |
| Q40640830 | Cost-effective strategies for autologous blood procurement before surgery |
| Q40607408 | Current issues in platelet transfusion therapy |
| Q40901529 | Donor deferral registries. |
| Q41096834 | Epidemiology of red blood cell utilization |
| Q34599699 | Exogenous c-Myc Blocks Differentiation and Improves Expansion of Human Erythroblasts In vitro |
| Q93053082 | First-time Blood Donors Are Double-edged Swords for Blood Transfusion Centers: A Retrospective Study in Southwest Iran |
| Q73656620 | Flow cytometric analysis of platelet membrane antigens during and after continuous-flow plateletpheresis |
| Q38840932 | Genetically Engineered In Vitro Erythropoiesis |
| Q40702646 | Health and economic consequences of HCV lookback |
| Q77221377 | Hematocrit value on intensive care unit entry influences the frequency of Q-wave myocardial infarction after coronary artery bypass grafting. The Institutions of the Multicenter Study of Perioperative Ischemia (McSPI) Research Group |
| Q67484167 | How Safe Is Safe Enough? New Infections and the U.S. Blood Supply |
| Q70708893 | Hypovolemic shock |
| Q35989798 | Impact of anemia in patients with head and neck cancer treated with radiation therapy |
| Q35804510 | Infectious and immunologic consequences of blood transfusion |
| Q73127453 | Isovolemic hemodilution with a bovine hemoglobin-based oxygen carrier: effects on hemodynamics and oxygen transport in comparison with a nonoxygen-carrying volume substitute |
| Q38489482 | Monitoring transfusion practice--a computerized procedure |
| Q40703862 | Oxygen carriers and transfusion medicine |
| Q57103831 | Patients' willingness to pay for autologous blood donation |
| Q33867781 | Perioperative autologous blood donation in children |
| Q35572810 | Perioperative blood and blood product management for spinal deformity surgery |
| Q33353785 | Perioperative haemotherapy: I. Indications for blood component transfusion |
| Q70662230 | Phlebotomy--a minimalist approach |
| Q74483006 | Platelet function testing in apheresis products: flow cytometric, resonance thrombographic (RTG) and rotational thrombelastographic (roTEG) analyses |
| Q74055981 | Platelet transfusions: utilization and associated costs in a tertiary care hospital |
| Q33581221 | Pooled platelet concentrates: maybe not fancy, but fiscally sound and effective |
| Q34622495 | Primary total knee arthroplasty allogenic transfusion trends, length of stay, and complications: nationwide inpatient sample 2000-2009. |
| Q33349172 | Prophylactic platelet transfusions: which dose is the best dose? A review of the literature |
| Q40596235 | Red cell transfusion therapy in chronic anemia. |
| Q38456251 | Regional and temporal variation in American Red Cross blood donations, 1995 to 2005. |
| Q35178903 | Safety in Transfusion Practices: Red Cell Compatibility Testing Issues |
| Q33956734 | Temporal and demographic patterns of non-Hodgkin's lymphoma incidence in Pennsylvania |
| Q34941829 | The Blood Stocks Management Scheme, a partnership venture between the National Blood Service of England and North Wales and participating hospitals for maximizing blood supply chain management |
| Q34092295 | The Changing Epidemic of HIV. |
| Q33845066 | The effect of Epoetin alfa on quality of life in anemic cancer patients |
| Q40990051 | The impact of HIV testing on blood utilization in the intensive care unit in patients with gastrointestinal bleeding |
| Q33582595 | The role of flow cytometry in improving biocompatibility in transfusion medicine |
| Q40517931 | The role of hematopoietic growth factors in transfusion medicine. |
| Q71116053 | The role of hemoglobin based blood substitutes in transfusion medicine |
| Q33582608 | The transfusion audit as a tool to improve transfusion practice: a critical appraisal |
| Q35597837 | Thromboerythrocytes. In vitro studies of a potential autologous, semi-artificial alternative to platelet transfusions |
| Q40473574 | Transfusion Medicine in Obstetrics and Gynecology |
| Q33382675 | Transfusion and the use of blood products |
| Q33332057 | Transfusion of platelet concentrates cryopreserved with ThromboSol plus low-dose dimethylsulphoxide in patients with severe thrombocytopenia: a pilot study. |
| Q40630687 | Transfusion-associated bacterial sepsis |
| Q40378124 | Use of Oxygent, a perfluorochemical-based oxygen carrier, as an alternative to intraoperative blood transfusion |
| Q43572627 | Utilization of technologies to reduce allogeneic blood transfusion in the United States |
| Q37717532 | Valuation of the benefits of risk-free blood. Willingness to pay for hemoglobin solutions |
Search more.